Immunitybio

ImmunityBio is a biotechnology company focused on developing innovative immunotherapy treatments for cancer and infectious diseases. They generate revenue through the research, development, and commercialization of their proprietary therapies, which include cell-based treatments, vaccines, and immune-modulating drugs. Founded by Dr. Patrick Soon-Shiong, the company has a significant history of advancing clinical trials and securing strategic partnerships to enhance their therapeutic pipeline. Their mission is to harness the power of the immune system to combat life-threatening diseases, aiming to provide more effective and safer treatment options for patients worldwide.

Recent Posts by Immunitybio

1-20 of 516